Salta al contenuto principale
Passa alla visualizzazione normale.


Pari opportunit�

Ricerca avanzata per:

Risultati della ricerca

  • 1. AISF – Fegato grasso, colpito il 25% della popolazione. Più a rischio obesi e diabetici. Nuovi studi italiani migliorano prevenzione, diagnosi e follow up (100%)

    27-mar-2023 9.20.56

    AISF – Fegato grasso, colpito il 25% della popolazione. Più a rischio obesi e diabetici. Nuovi studi italiani migliorano prevenzione, diagnosi e follow up articolo, notizia, unipa, aisf, Fegato grasso, obesi, diabetici, NAFLD, Non Alcoholic Fatty Liver Disease, Steatosi epatica non alcolica, Vincenza Calvaruso, intervista, terza missione, public_engagement, Dall’Università di Palermo uno studio conferma l’Elastografia epatica tramite Fibroscan® come strumento migliore per accuratezza

  • 2. CV_modello_europeo_CAMMA con pubblicazioni 12 2019 (85%)

    9-mar-2021 18.51.36

    Variant and Liver-Related Outcomes in Patients with Non-alcoholic Fatty Liver Disease. Clin ... platelet in non-alcoholic fatty liver disease cirrhosis. J Hepatol. 2018 Oct;69(4):878-885. doi: 10.1016 ... of liver disease in subjects with non-alcoholic fatty liver disease (NAFLD): a case control study ... in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2017 Feb;45(4):510-518 ... Damage and Atherosclerosis in Patients with Non-Alcoholic Fatty Liver Disease. PLoS One. 2015 Dec 16;10

  • 3. CV Ciro Celsa ITA (74%)

    26-feb-2020 10.14.44

    rs738409 C>G Variant and Liver-Related Outcomes in Patients with Non-alcoholic Fatty Liver Disease ... -Related Outcomes in Patients with Non-Alcoholic Fatty Liver Disease. Available at SSRN 3347913. 2019 ... A, et al. P162 Prevalence of nafld (non alcoholic fatty liver disease) and fibrosis in inflammatory ... , Giammanco A, Spatola F, Petta S. The Burden of Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver ... Fatty Liver Disease: What Drugs Are Available Now and Future Perspectives. Int J Environ Res Public

  • 4. cv licata (63%)

    20-ott-2022 12.17.03

    with Liver Damage and Atherosclerosis in Patients with Non-Alcoholic Fatty Liver Disease. PLoS One ... with Non-alcoholic Fatty Liver Disease. AP&T submitted Aliment Pharmacol Ther. 2017 Feb;45(4):510-518 ... Induced Liver Injury (DILI) and Non-Alcoholic Fatty Liver Disease (NAFLD). Eur J of Med Health Sci 2 ... on the outcome of Non-Alcoholic Fatty Liver Disease. Int J Mol Sci. 2022 Mar 27;23(7):3668. doi: 10.3390 ... -alcoholic fatty liver disease (NAFLD): a case control study. Cardiovasc Diabetol. 2018 Feb 16;17(1):28. doi

  • 5. convocazione CdD 2025-12-22 (47%)

    19-gen-2026 12.59.17

    medicine to stratify disease severity and outcomes of patients with non-alcoholic fatty liver disease ... severity and outcomes of patients with non-alcoholic fatty liver disease by using artificial

  • 6. cv nicoletti (41%)

    16-gen-2018 14.47.25

    Chitotriosidase gene expression in Kupffer cells from patients with non-alcoholic fatty liver disease

  • 7. 2014_2722_bando craxì med 12 (40%)

    18-lug-2014 13.54.26

    significant fibrosis in patients with non-alcoholic fatty liver disease - Descrizione ... invasivi. - Description: Non-alcoholic fatty liver disease (NAFLD) is the hepatic expression

  • 8. 5363300 bando_prin2022_prof. petta_en (40%)

    19-mar-2024 9.27.36

    medicine to stratify disease severity and outcomes of patients with non- alcoholic fatty liver disease ... : Precision medicine to stratify disease severity and outcomes of patients with non-alcoholic fatty liver disease by using artificial Intelligence, to be carried out at the Department of Health

  • 9. medicina del benessere, nutrogenomica e malattie degenerative (33%)

    25-lug-2017 12.19.00

    (Non Alcoholic Fatty Liver Disease) (NAFLD) is defined by the presence of a wide spectrum

  • 10. BIND - Documento Allegato a Riesame 2019 (33%)

    7-ott-2020 10.47.54

    in attesa liver fibrosis in Non Alcoholic Fatty Liver Disease by serum markers, FibroScan, MR

  • 11. Locandina Gastro-Day 2019 (33%)

    12-nov-2019 16.13.25

    : Outcome clinici nei pazienti con colangite biliare primitiva Ore 10.20 Barbara Scrivo: La NAFLD (Non Alcoholic Fatty Liver Disease) nelle malattie infiammatorie croni- che intestinali: analisi dei fattori

  • 12. medicina-del-benessere-nutrogenomica-e-malattie-degenerativeXXXIII ciclo (33%)

    19-giu-2017 14.04.25

    (Non Alcoholic Fatty Liver Disease) (NAFLD) is defined by the presence of a wide spectrum

  • 13. Esiti CdD del 2025-12-22 (33%)

    19-gen-2026 13.28.14

    outcomes of patients with non-alcoholic fatty liver disease by using artificial Intelligence

  • 14. cv rodella (28%)

    10-lug-2018 10.08.25

    to microsteatosis by melatonin supplementation in ob/ob mice non-alcoholic fatty liver disease

  • 15. MdG Newsletter luglio 2021 (28%)

    8-set-2021 13.54.56

    of sexual dimorphism in non- alcoholic fatty liver disease (NAFLD) and non- Int J Mol Sci. 2021; 22

  • 16. Albo Dottori XXIV ciclo Anno 2014 (28%)

    24-giu-2021 9.52.29

    ALTIERI GRAZIA IDA PALERMO PA 29/12/1985 SFINGO-LIPIDOMICA DELLA NON ALCOHOLIC FATTY LIVER DISEASE

  • 17. 31052011BANDO-RIC-T-D-MED-12-16 (28%)

    8-mar-2013 21.38.20

    clinica dei fattori metabolici nei pazientinnnt.i con Non-Alcoholic Fatty Liver Disease"

  • 18. MED-12_MED-16_bando_TD (28%)

    8-mar-2013 19.10.43

    dei fattori metabolici nei pazienti con epatite cronica da virus C e nei pazienti con Non-Alcoholic Fatty Liver Disease”; VISTE le delibere del 05.04.2011 nn. 52 e 55 con le quali il Senato Accademico

  • 19. Riesame_Ricerca_TM_dipartimentale_2021 - PROMISE 23.05.2022_ (28%)

    18-lug-2022 12.20.49

  • 20. PROMISE_Riesame_Ricerca_TM_dipartimentale_2021 - PROMISE 23.05.2022 (28%)

    15-giu-2022 18.15.59